Mirum Pharmaceuticals Inc’s recent filing unveils that its PRESIDENT AND COO Radovich Peter unloaded Company’s shares for reported $0.13 million on Feb 03 ’25. In the deal valued at $48.22 per share,2,627 shares were sold. As a result of this transaction, Radovich Peter now holds 26,961 shares worth roughly $1.35 million.
Then, Peetz Christopher sold 9,102 shares, generating $438,921 in total proceeds. Upon selling the shares at $48.22, the CHIEF EXECUTIVE OFFICER now owns 115,920 shares.
Before that, Howe Jolanda sold 1,064 shares. Mirum Pharmaceuticals Inc shares valued at $51,309 were divested by the SVP, GLOBAL CONTROLLER at a price of $48.22 per share. As a result of the transaction, Howe Jolanda now holds 4,232 shares, worth roughly $0.21 million.
Stifel initiated its Mirum Pharmaceuticals Inc [MIRM] rating to a Buy in a research note published on April 17, 2024; the price target was $48. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who remained covering the stock and in mid December has reiterated a ‘”a Buy”‘ rating for it. Morgan Stanley started covering the stock on November 13, 2023. It rated MIRM as “an Overweight”.
Price Performance Review of MIRM
On Tuesday, Mirum Pharmaceuticals Inc [NASDAQ:MIRM] saw its stock fall -2.00% to $49.93. Over the last five days, the stock has lost -5.26%. Mirum Pharmaceuticals Inc shares have risen nearly 20.75% since the year began. Nevertheless, the stocks have risen 76.93% over the past one year. While a 52-week high of $54.23 was reached on 02/21/25, a 52-week low of $23.14 was recorded on 01/10/25. SMA at 50 days reached $46.34, while 200 days put it at $39.63.
Levels Of Support And Resistance For MIRM Stock
The 24-hour chart illustrates a support level at 48.88, which if violated will result in even more drops to 47.83. On the upside, there is a resistance level at 51.36. A further resistance level may holdings at 52.79. The Relative Strength Index (RSI) on the 14-day chart is 51.78, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.18, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 75.46%. Stochastics %K at 47.41% indicates the stock is a holding.
The most recent change occurred on October 24, 2023 when Cantor Fitzgerald began covering the stock and recommended ‘”an Overweight”‘ rating along with a $50 price target.
